Mira Pharmaceuticals Files 8-K: Other Events
Ticker: MIRA · Form: 8-K · Filed: Oct 15, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Oct 15, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $70 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
TL;DR
Mira Pharma filed an 8-K for 'Other Events' on Oct 15, 2025. Details TBD.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on October 15, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company was formerly known as Mira1a Therapeutics, Inc. and changed its name on January 12, 2022.
Why It Matters
This 8-K filing indicates a material event has occurred for Mira Pharmaceuticals, but the lack of specific details leaves investors uncertain about the nature and impact of this event.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, creating uncertainty about potential material impacts on the company.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- October 15, 2025 (date) — Filing date and earliest event reported
- January 12, 2022 (date) — Date of former company name change
FAQ
What specific 'Other Events' are being reported by Mira Pharmaceuticals, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' beyond the general categorization.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on October 15, 2025, which is also the date of the report.
What was Mira Pharmaceuticals, Inc. formerly known as?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc.
When did the company change its name from Mira1a Therapeutics, Inc.?
The company changed its name from Mira1a Therapeutics, Inc. on January 12, 2022.
What is the principal executive office address for Mira Pharmaceuticals, Inc.?
The principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
Filing Stats: 671 words · 3 min read · ~2 pages · Grade level 15.8 · Accepted 2025-10-15 16:01:39
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
- $70 billion — ns and reinforcing MIRA's position in a $70 billion non-opioid pain market. On October 15
Filing Documents
- form8-k.htm (8-K) — 41KB
- 0001493152-25-018141.txt ( ) — 205KB
- mira-20251015.xsd (EX-101.SCH) — 3KB
- mira-20251015_lab.xml (EX-101.LAB) — 33KB
- mira-20251015_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: October 15, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer